Pressure Biosciences (PBIO) Downgraded by ValuEngine to “Hold”

Share on StockTwits

ValuEngine lowered shares of Pressure Biosciences (OTCMKTS:PBIO) from a buy rating to a hold rating in a research report sent to investors on Thursday, ValuEngine reports.

PBIO traded up $0.10 during trading on Thursday, reaching $3.25. The stock had a trading volume of 1,557 shares, compared to its average volume of 7,064. Pressure Biosciences has a 1-year low of $1.52 and a 1-year high of $4.10.

About Pressure Biosciences

There is no company description available for Pressure Biosciences Inc

Featured Article: Quiet Period

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Pressure Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pressure Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Infosys  Upgraded at Zacks Investment Research
Infosys Upgraded at Zacks Investment Research
Nostrum Oil & Gas  Stock Rating Reaffirmed by Peel Hunt
Nostrum Oil & Gas Stock Rating Reaffirmed by Peel Hunt
Dimensional Fund Advisors LP Decreases Holdings in Gannett Co Inc
Dimensional Fund Advisors LP Decreases Holdings in Gannett Co Inc
Restoration Robotics’  Hold Rating Reaffirmed at Maxim Group
Restoration Robotics’ Hold Rating Reaffirmed at Maxim Group
Itau Unibanco Holding SA  Stake Lowered by Bp Plc
Itau Unibanco Holding SA Stake Lowered by Bp Plc
HC Wainwright Reaffirms “Buy” Rating for Blink Charging
HC Wainwright Reaffirms “Buy” Rating for Blink Charging


© 2006-2019 Ticker Report